GRP and breast carcinoma: The same research group studied [46] 177Lu-dendrimer(PAMAM-G4)-folate-bombesin with gold nanoparticles (AuNPs) in the dendritic cavity as a theragnostic tracer of breast cancer expressing folate receptors (FRs) and gastrin-releasing peptide receptors (GRPRs).